Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Aug 2.
Published in final edited form as: Anal Chem. 2020 Jun 29;92(14):9536–9545. doi: 10.1021/acs.analchem.0c00591

Phosphorus NMR and its application to metabolomics

Fatema Bhinderwala 1,2, Paula Evans 1, Kaleb Jones 1, Benjamin R Laws 1, Thomas Smith 1,2, Martha Morton 1,2, Robert Powers 1,2,*
PMCID: PMC8327684  NIHMSID: NIHMS1727421  PMID: 32530272

Abstract

Stable isotopes are routinely employed by NMR metabolomics to highlight specific metabolic processes and to monitor pathway flux. 13C-carbon and 15N-nitrogen labeled nutrients are convenient sources of isotope tracers and are commonly added as supplements to a variety of biological systems ranging from cell cultures to animal models. Unlike 13C and 15N, 31P-phosphourous is a naturally abundant and NMR active isotope that doesn’t require an external supplemental source. To date, 31P NMR has seen limited usage in metabolomics because of a lack of reference spectra, difficulties in sample preparation, and an absence of two-dimensional (2D) NMR experiments. But, 31P NMR has the potential of expanding the coverage of the metabolome by detecting phosphorous-containing metabolites. Phosphorylated metabolites regulate key cellular processes, serve as a surrogate for intracellular pH conditions, and provides a measure of a cell’s metabolic energy and redox state, among other processes. Thus, incorporating 31P NMR into a metabolomics investigation will enable the detection of these key cellular processes. To facilitate the application of 31P NMR in metabolomics, we present a unified protocol that allows for the simultaneous and efficient detection of 1H-, 13C-, 15N- and 31P-labeled metabolites. The protocol includes the application of a 2D 1H-31P HSQC-TOCSY experiment to detect 31P-labeled metabolites from heterogeneous biological mixtures, methods for sample preparation to detect 1H-, 13C-, 15N- and 31P-labeled metabolites from a single NMR sample, and a dataset of one-dimensional (1D) 31P NMR and 2D 1H-31P HSQC-TOCSY spectra of 38 common phosphorus-containing metabolites to assist in metabolite assignments.

Keywords: 31P-NMR, Metabolite identification, Metabolome coverage, HSQC-TOCSY

Graphical Abstract

graphic file with name nihms-1727421-f0001.jpg

Introduction

Metabolome profiling techniques have evolved from primitive smell and taste tests to utilizing state-of the art analytical instruments.1 Mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy are the analytical instrumentation of choice in current metabolomics research.2 Despite contributing to numerous successes ranging from drug discovery to preventing food adulteration,35 NMR-based metabolomics still faces a number of significant challenges. These include the need for rapid and reliable metabolite annotation, for identifying unknowns, and for increasing the detection of low concentration or transient metabolites. While an NMR metabolomics experiment may detect upwards of a hundred metabolites, the total human metabolome is estimated to consist of approximately 150,000 metabolites.6 Thus, for a give cell or biological system the majority of chemical entities comprise the dark metabolome.

Metabolomics relies heavily on the availability of NMR databases that contain various spectral information for known metabolites. Metabolite assignments are thus made by matching the experimental NMR data (e.g., chemical shifts, coupling constants) with reference spectra or data from these databases. A number of NMR databases are available to the metabolomics community.710 While a valuable resource, most NMR databases are heavily populated with 1D 1H and 2D 1H-13C HSQC NMR spectra for commonly available metabolites. There are on-going efforts to improve database integration, to enhance user tools (e.g., queries), and to expand the spectral content within these databases; however, this has been predominantly directed towards including additional 1D 1H NMR and 2D 1H-13C HSQC spectra for new compounds. This is primarily in response to the routine use of Stable Isotope Resolved Metabolomics (SIRM) experiments, which have nearly exclusively focused on incorporating 13C-carbon labels into the metabolome. Accordingly, various annotation methods have been employed based on 1H-1H or 1H-13C type NMR spectra.1114

Expanding the coverage of the metabolome beyond central carbon metabolism requires alternative SIRM strategies. We and others have recently reported the successful application of 15N-NMR to characterize nitrogen-based metabolism in bacterial and mammalian cells by supplementing cell cultures with 15N labeled amino acids.15, 16 Notably, our protocol allowed for the simultaneous detection of both 13C- and 15N-labeled metabolites from a single NMR sample, an effective double-labeled SIRM approach. SIRM methods are an excellent approach for identifying and quantifying metabolites that are not otherwise observed using a 1D 1H NMR untargeted approach.15 Employing a double-labeled SIRM approach provides a larger coverage of the metabolome, which leads to a better understanding of cellular chemistry or a better approach for identifying biomarkers. While combining 13C- and 15N-based SIRM into a single metabolomics strategy expands the metabolome coverage, why limit the approach to just carbon and nitrogen metabolism? There are other nuclei of biological importance that are NMR active and naturally abundant, such as 31P-phosphorous-containing metabolites. Combining 31P-NMR with a multi-labeled SIRM approach will only further enhance the metabolome coverage.

31P-NMR is an obvious choice to add to an existing multi-labeled SIRM approach to metabolomics since 31P is 100% abundant, an NMR active nucleus, and more sensitive than 13C-NMR and 15N-NMR. More importantly, phosphorus is present in numerous metabolites that regulate major cellular processes. In fact, phosphorylated metabolites may comprise upwards of 36% of the known metabolome (based on the percentage of phosphorylated metabolites in HMDB).7 NMR is also uniquely capable of simplifying spectral information by using nuclei-specific filtering, which provides an elegant and robust way to only observe phosphorylated metabolites.

1D 31P NMR was extensively used in the early application of NMR to study cellular biochemistry,17 to investigate various diseases,18, 19 as a tool of synthetic chemistry,20 and to explore DNA and RNA structures.2123 But, 31P-NMR methods have seen limited use of late, have not been systematically assessed for metabolomics application, and a robust workflow has not been developed to facilitate a wider-adoption by the metabolomics community. There are a number of known challenges to the application of 31P-NMR to metabolomics, such as a lack of chemical shift references, the large pH and temperature dependence of the chemical shifts, and the poor line shapes that are further complicated by various phosphorus ionization states and the diversity of bound ions. There has also been the perception that at higher magnetic field strengths chemical shift anisotropy would render the 31P spectrum useless with no baseline resolution of peaks. However, by addressing these concerns, 31P -NMR may serve the NMR-metabolomics community and shed some light on the dark metabolome.

Herein, we systematically explored the potential for 31P-based NMR metabolomics. 1D 31P and various different 2D pulse sequences were evaluated, and an optimized 2D 1H-31P HSQC-TOCSY spectrum is proposed as the preferred choice to identify phosphorus-containing metabolites. A set of 1D 31P and 2D 1H-31P HSQC-TOCSY spectra for 38 common phosphorus compounds have been acquired to aid in the annotation of phosphorus-containing metabolites. Importantly, an overall protocol for a multi-nuclei approach to metabolomics is presented that provides an efficient integration of 31P-NMR with multi-SIRM for the simultaneous detection of 1H, 13C, 15N and 31P-containing metabolites from a single NMR sample. In total, the multi-nuclei metabolomics protocols and reference spectra are expected to enable the metabolomics community to adopt 31P-NMR for characterizing biological samples and expanding the coverage of the metabolome.

Methods

Study design.

An overview of the series of experiments used to optimize and implement a 31P NMR protocol into a multi-nuclei metabolomics workflow is diagramed in Figure 1. As described in detail in the Supporting Information, a series of standard metabolite and metabolite mixture samples (Tables S1 and S2) were used to optimize experimental parameters, sample conditions and metabolome extraction protocols; and to identify the preferred 31P NMR pulse sequence. Specifically, a range of pH values (2, 4, 7, 10 and 12), temperatures (277, 286 and 298K), Mg+2 concentrations (0.1 to 10 mM), and EDTA concentrations (0.1 to 10 mM) were investigated to optimize sample conditions in order to maximize spectral quality and sample stability. Similarly, different extraction solvents (100% water, 1:1 water:methanol, and 1:1 methanol:chloroform), cell lysing techniques (wand sonicator, water-bath sonicator, FastPrep bead beating), and sample drying (SpedVac and lyophilizer) were investigated to maximize the presence of phosphorylated-metabolites in a metabolomics sample. 1D 31P, 2D 1H–31P HSQC-TOCSY and 2D 1H–31P HMBC pulse sequences were explored to identify the preferred 31P NMR pulse sequence. Also, the one-bond 1JX-H coupling constant (160 to 200 Hz), the long range nJX-H coupling constant (5 to 10 Hz), and the TOCSY mixing time (70 to 120 msec) were optimized to maximize spectral quality and the number of detectable NMR resonances. Please see the Supporting Information for further details on the routine protocols used for NMR data collection, processing, and metabolite assignments, and for the list of chemicals used in this study.

Figure 1.

Figure 1.

Summary of sample preparations, optimization matrix and standard samples used to develop a multinuclei metabolomics workflow incorporating 31P NMR. (A) Identification of the preferred 2D 1H-31P NMR pulse sequence using a standard 2 mM ADP sample. The one-bond 1JX-H coupling constant (160 to 200 Hz), the long range nJX-H coupling constant (5 to 10 Hz), and the TOCSY mixing time (70 to 120 msec) were optimized. (B) The impact of a Mg2+ counter ion or a chelator (EDTA) on the ADP 31P NMR spectral quality was examined. Similarly, the impact of (C) pH and (D) temperature on ADP peak width and intensity in both 1D and 2D 31P NMR spectra were evaluated. (E & F) The stability of phosphorylated-metabolites were investigated across a range of experimental conditions using a series of 2D 1H-31P HSQC-TOCSY experiment collected on two different metabolite mixtures (adenosine analogs and sugar phosphates). A range of pH values, extraction solvents, and cell lysing techniques were investigated.

Results and Discussions

Optimization of NMR experimental parameters

Phosphorus chemical shifts and line shapes are significantly influenced by solvent, pH, counter ion, ionic strength and temperature. 31P resonances have a limited chemical shift dispersion and tend to be broad, leading to obscured peak splitting. Furthermore, phosphorus-containing metabolites are of relatively low stability. Consequently, 31P NMR has seen limited application in recent metabolomics studies despite being a 100% abundant nuclei with relatively high sensitivity. Instead, NMR researchers tend to utilize the incorporation of expensive 13C and 15N isotope labeling to characterize the metabolome. Alternatively, natural abundant 13C-NMR is also routinely employed for the analysis of biofluids, but at the expense of longer NMR acquisition time.24, 25 Of course, either approach may limit the coverage of the metabolome while providing an incomplete view of system perturbations. To address some of the inherent challenges with 31P NMR and to increase its broad application, a variety of experimental conditions were investigated to develop a routine and robust 31P NMR metabolomics approach. An ideal NMR metabolomics experiment has four defining characteristics: (i) sharp, resolved and quantifiable peaks, (ii) highly stable and reproducible data, (iii) high-throughput and rapid data acquisition, and (iv) sufficient spectral information to readily identify the compounds. In this regards, 2D 1H-31P pulse sequences were systematically evaluated to identify an ideal experiment for the identification and quantification of phosphorous-containing metabolites.

The 2D 1H-31P HSQC-TOCSY and 1H-31P HMBC pulse sequences were first evaluated using adenosine diphosphate (ADP). An overlay of the two ADP spectra is shown in Figure 2A. The spectral overlay clearly highlights the significant increase in spectral information in the 2D 1H-31P HSQC-TOCSY spectrum relative to the HMBC spectrum. A greater number of 1H-31P correlations were observed in the HSQC-TOCSY spectrum, which are critical for an accurate identification of phosphorous-containing metabolites. Simply, the limited 31P chemical shift dispersion makes it difficult to make an unambiguous metabolite assignment based strictly on 31P chemical shifts. This occurs because most phosphorous-containing compounds are structurally similar to other metabolites. For example, the phosphate group within both adenosine monophosphate (AMP) and cytidine monophosphate (CMP) are attached to the same sugar moiety. Thus, accurate metabolite assignments require correlated 1H chemical shifts. Accordingly, we focused our further efforts on optimizing the 2D 1H-31P HSQC-TOCSY experimental parameters to maximize its utility in a metabolomics study. Notably, Gradwell et al. supported our conclusion, where the 2D 1H-31P HSQC-TOCSY experiment was successfully used to identify metabolites from a complex mixture derived from crayfish.18

Figure 2.

Figure 2.

Representative examples of 2D 1H-31P NMR spectra. (A) Overlay of 2D 1H-31P HSQC-TOCSY (blue) and 2D 1H-31P HMBC (red) spectra acquired for a 1 mM solution of adenosine diphosphate (ADP) in 90:10 water: D2O solution at pH 4. (B) Overlay of 2D 1H-31P HSQC-TOCSY spectra with an 80 msec TOCSY mixing time for 2 mM solution of adenosine monophosphate (AMP) (blue), adenosine diphosphate (ADP) (red) and ATP (green) in 90:10 water: D2O solution at pH 4.

A series of 2D 1H-31P HSQC-TOCSY spectra were collected using the ADP sample while varying the one-bond 1JX-H coupling constant, the long range nJX-H coupling constant, and the TOCSY mixing time. Specifically, the 1JX-H values were varied between 160 and 200 Hz (20 Hz increments), the nJX-H values were varied between 5 and 10 Hz (1 Hz increment), and the mixing time was varied between 70 and 120 msec (10 msec increment). All other experimental parameters remained constant. The resulting spectral data set were qualitatively evaluated based on the number of observed 1H-correlations and the overall spectral signal-to-noise. Notably, the choice of TOCSY mixing time had the greatest impact on spectral quality (Figure 2B). The optimal 2D 1H-31P HSQC-TOCSY experiment used a one-bond 1JX-H coupling constant of 200 Hz, a long range nJX-H coupling constant of 8 Hz, and a TOCSY mixing time of 80 msec. A similar effort to optimize the 2D 1H-31P HMBC experiment yielded no improvement to the spectrum shown in Figure 2A.

Optimization of sample preparation parameters

31P chemical shifts may be sensitive to the type and charge of counter ions present in the sample buffer. For example, magnesium ion (Mg+2) is traditionally used in DNA structural analysis to aid in 31P chemical shift dispersion.19, 2628 Thus, the impact of double charged counter ion species on common phosphorus-containing metabolites was evaluated. Specifically, AMP, ADP and ATP NMR samples were titrated with upwards of 10 mM of MgCl2 or EDTA. The 31P chemical shift variation was monitored as a function of each titrant. Only a minimal impact on the β and α phosphate signal was observed in the 1D 31P spectrum (Figures 3A, B). Similarly, the chemical shifts in the 2D 1H-31P HSQC-TOCSY spectrum (Figure 3A) was essentially unaffected by the addition of Mg+2. While the addition of Mg+2 had a minimal impact on 31P chemical shifts, it did affect peak shape and line widths. The effect of Mg+2 on 31P line shape may be explained by a change in the P-OH bond angle.29 A bound Mg+2 likely restricts the free movement of the outer-most phosphate, which leads to a rigid structure and sharp lines. Thus, the addition of Mg+2 improves the overall quality of the 31P spectrum by decreasing linewidth while minimally impacting chemical shifts. Accordingly, an optimal 31P spectrum is achieved by adding 2 mM of Mg+2 to each metabolomics sample, but the addition of Mg+2 is not essential.

Figure 3.

Figure 3.

Impact of pH and temperature on 1D and 2D 31P NMR spectra. Stacked plots of 1D 31P spectra for 2 mM solution of AMP (blue), ADP (red) and ATP (green) in 90:10 water:D2O solution at pH 4 (A) without and (B) with the addition of 2 mM Mg+2. (C) Stacked plots of 1D 31P spectra for 2 mM solution of ADP in 90:10 water:D2O solution at pH values of 2, 4, 7, 10, and 12. (D) Overlay of 2D 1H-31P HSQC-TOCSY spectra of 1 mM solution of ADP in 90:10 water:D2O at three different temperatures corresponding to 298K (black), 286K (grey) and 277K (red).

As previously demonstrated with our combined 13C and 15N SIRM protocol,30 the proper choice of pH and temperature are integral to streamlining a multi-nuclei metabolomics workflow. Accordingly, the effect of pH and temperature on 31P chemical shifts and peak intensities were thoroughly investigated. A stacked plot of 1D 31P spectra for ADP at pH values ranging from 2 to 12 is shown in Figure 3C. The impact of pH on the quality of the 31P spectrum was quite dramatic, and is likely attributed to changes in both the stability and ionization state of the phosphate group. This is consistent with previous reports that the stability of ATP is increased at either acidic or basic pH values.31, 32 Accordingly, a pH of 4 was determined to be optimal for collecting a 31P spectrum of metabolomics samples. Importantly, a low pH is also compatible with the sample conditions we previously reported for detecting nitrogen-containing metabolites.

An overlay of the 2D 1H-31P HSQC-TOCSY spectra for ADP at three different temperatures (277, 286 and 298K) is shown in Figure 3D. Not surprisingly, temperature also impacted the quality of the NMR spectrum for phosphorus-containing metabolites. In addition to the expected uniform downfield temperature-dependent shift, an increase in temperature also resulted in a broadening of peaks and a loss in some observable 1H-correlations. Accordingly, the best-quality 2D 1H-31P HSQC-TOCSY spectrum was obtained at 277K. Two mixtures comprised of different sets of phosphorus-containing metabolites (e.g., sugar phosphates, and adenosine analogs) were used to further verify (data not shown) that a sample pH of 4 and a temperature of 277K yielded the best results. To summarize, a 2D 1H-31P HSQC-TOCSY spectrum at 277K of a metabolomics sample prepared in 10% D2O/90% H2O titrated to a pH of 4 provides the best approach to properly characterize phosphorus-containing metabolites. Please note, a standard phosphate buffer is not recommended because of dynamic range problems with low abundant metabolites. Furthermore, the addition of other buffers is also not preferred since it may require a buffer exchange and extensive sample handling to collect subsequent 1H, 13C and 15N spectra from the same metabolomics sample. Since 31P chemical shifts are very pH sensitive, care is required to minimize any pH variance between NMR metabolomics samples. This is achievable by either using an internal pH standard or by manually verifying each sample’s pH value, which is our preferred method.

Database of 1D 31P and 2D 1H-31P HSQC-TOCSY spectra for common metabolites

A set of 1D 31P and 2D 1H-31P HSQC-TOCSY spectra were acquired for 38 readily accessible phosphorus-containing compounds (Table S1) utilizing the optimized experimental parameters described above. The set of 38 metabolites consists of a wide variety of chemically distinct phosphate compounds that are primarily monophosphates. The metabolites can be grouped into six general classes comprising amino acids, cholines and others, coenzymes, glycerols, nucleic acid analogs, and sugars (Figure 4A, C). A good quality NMR spectrum was acquired for all compounds at a concentration of 2 mM. The 1D 31P and 2D 1H-31P HSQC-TOCSY spectra required a total acquisition time of approximately one hour. The 2D 1H-31P HSQC-TOCSY experiment was collected using non-uniform sampling at a 25% sparsity with our deterministic sampling scheme.33 A few representative 2D 1H-31P HSQC-TOCSY spectra are shown in Figure 3B-D, which correspond to dihydroxy acetone phosphate (both keto and enol resonance forms arpresent),34 glycerol-1-phosphate and mannose-6-phosphate. Notably, dihydroxy acetone phosphate and glycerol-1-phosphate are glycolytic intermediates, which are crucial regulatory steps and connect to other principle pathways. While the compounds have similar structures, a distinct peak pattern is observed in the 2D 1H-31P HSQC-TOCSY spectrum enabling easy metabolite assignments. The chemical shifts from the 1D 31P and 2D 1H-31P HSQC-TOCSY spectra are summarized in Tables S1 and S2. Two different sets of spectral data are provided, one corresponding to the pH that simply results from dissolving the metabolites in water and another where all the metabolites were adjusted to a final pH of 4. Unsurprisingly, phosphorus-containing compounds induce a wide range of pH values (2.3 to 7.7) in an unbuffered solution. The database of 31P NMR spectra provides a means to readily assign metabolites detected in cell lysates or other biological samples. Phosphorylated metabolites are often hard to distinguish using routine 1H and 13C spectral data. To further facilitate the assignment of phosphorylated metabolites, 2D 1H-13C HSQC spectra of the 38 phosphorylated metabolites was also collected at pH 4. The pH 4 1H and 13C chemicals shifts are listed in Table S3.

Figure 4.

Figure 4.

Representative 2D 1H -31P HSQC-TOCSY spectra using a 80 msec mixing time for (A) mannose-6-phosphate, (B) glycerol-1-phosphate, and (C) dihydroxy acetone phosphate (enol (blue) and keto (red) forms are labeled). The chemical structures are shown under each spectrum where each observed correlation is indicated by a circle. (D) Summary of the 38 phosphorylated compounds and their assigned chemical class for which 1D 31P and 2D 1H -31P HSQC-TOCSY spectra were acquired.

Stability of phosphorous-containing metabolites and the impact of extraction protocols

Phosphorylated metabolites are prone to hydrolysis, which leads to the accumulation of inorganic phosphate and its related substrate.31, 35 The rate and extent of chemical hydrolysis is influenced by pH, temperature and the presence of counter ions.32 Phosphorylated metabolites are also prone to enzymatic hydrolysis.32 For example, in a cell lysate, the presence of active phosphatases may hasten the hydrolysis of labile phosphate groups, which may result in the loss of multiply phosphorylated species. Thus, sample handling and metabolome extraction processes may induce biologically irrelevant changes to the metabolome and lead to erroneous interpretations. To address these issues, the impact of common extraction processes on the stability of phosphorus-containing metabolites was evaluated with two different metabolite mixtures. One mixture consisted of adenosine nucleotide analogs and the second mixture contained sugar phosphates (Table S4).

Three common metabolite extraction processes were evaluated to identify an optimal sample preparation protocol for 31P NMR. The experimental design and extraction protocols are summarized in Figure 1. Each metabolite extraction protocol is comprised of three primary components: (i) an extraction solvent, (ii) cell lysing method, and (iii) a sample drying method. Accordingly, the adenosine analogs and sugar phosphate mixtures were treated with pure water or a 1:1 water:methanol extraction solvent. The samples were then either sonicated with a wand, water bath, or subjected to bead beating in Lysing matrix B using a FastPrep. The water:methanol samples where then dried using a combination of a SpeedVac evaporator and a lyophilizer. In total, 14 NMR samples were prepared, 7 for each of the adenosine analogs and sugar phosphate mixtures. The final NMR samples consisted of a 10% D2O/90% H2O solvent manually adjusted to a pH of 4. A 1D 31P spectrum and a 2D 1H-31P HSQC TOCSY spectrum was acquired for each sample. Representative 2D 1H-31P HSQC TOCSY spectra of the adenosine analog and sugar phosphate mixtures are shown in Figures S1 and S2, respectively.

As evident by the spectral overlays in Figures S1A, B, there was no detectable changes in the NMR spectra after sonication or sample drying. However, significant sample degradation was observed after subjecting the samples to a FastPrep bead beating (Figure S1C). Sample heating during the bead beating process along with the presence of the silica-based beads may have negatively impacted the stability of the adenosine analogs. The combination of sample drying and FastPrep bead beating also decreased the stability of the sugar phosphate mixture (Figure S2C). Notably, the decrease in the sugar phosphate mixture was not as pronounced as observed for the adenosine analog mixture. These results illustrate the importance of employing a mild metabolome extraction method to ensure maximum recovery of phosphorylated metabolites.

A multi-nuclei (1H, 13C, 15N and 31P) metabolomics workflow

Two bacterial cell lysates and a yeast cell lysate were used to demonstrate a multi-nuclei metabolomics workflow. Specifically, 1H, 13C, 15N and 31P NMR data are sequentially obtained from a single, multi-isotope labeled cell lysate. The overall multi-nuclei metabolomics protocol is summarized in Figure 5. Briefly, cells are cultured in a medium supplemented with both a 13C-labeled and a 15N-labeled nutrient. The metabolome is then extracted with a cold 1:1 methanol:chloroform solvent followed by mild sonication while keeping the sample on ice. The metabolomics sample is dried using a combined SpeedVac and lyophilizer and then reconstituted with 10% D2O/90% H2O that is manually titrated to a pH of 4. The 31P NMR spectrum is collected first because of the inherently lower stability of phosphorylated metabolites. It also solves the buffer problem. Most NMR metabolomics experiments are done with samples containing a millimolar concentration of a phosphate buffer. Such a high concentration of inorganic phosphate would be expected to mask any phosphorus-containing metabolites in the sample due to limitations in dynamic range. A 1D 31P spectrum and a 2D 1H-31P HSQC TOCSY spectrum are collected at 277K. The metabolomics sample is then adjusted to a pH of 2 by either the addition of DCl or an appropriate aliquot of a 1 M stock solution of a phosphate buffer at pH 2. The final metabolomics sample contains 25 mM of a phosphate buffer and 500 μM of TMSP. A 2D 1H-15N HSQC spectrum is collected at 277K. The sample is then titrated up to pH 7 with NaOD and a 1D 1H spectrum and a 2D 1H-13C HSQC spectrum are collected at 298K.

Figure 5.

Figure 5.

Summary of the Multi-nuclei NMR metabolomics workflow. 1H, 13C, 15N and 31P-metabolites are characterized from a single sample by collecting a sequential series of 2D NMR experiments corresponding to a 2D 1H-31P HSQC-TOCSY, 2D 1H-15N HSQC and 2D 1H-13C HSQC. The order of the experiments is intended to preserve the labile metabolites.

E. coli cells were grown in M9 minimal media supplemented with uniformly 13C-labeled glucose and 15NH3Cl as the sole carbon and nitrogen sources, respectively. Similarly, the sodium phosphate salts in the culture medium serves as the sole phosphate source for the bacteria. E. coli simply incorporates the 13C-carbon, the 15N-nitrogen and the phosphate into various cellular metabolites. An initial 2D 1H-31P HSQC TOCSY spectrum (data not shown) exhibited a very limited number of chemical shifts that were assigned to only a few monophosphorylated metabolites. This observation suggested that the extraction method may have resulted in the degradation of labile phosphorylated metabolites. The extraction process was subsequently modified by replacing the 1:1 water:methanol solvent with a 1:1 methanol:chloroform mixture. The resulting 2D 1H-31P HSQC TOCSY spectrum had a notable increase in the number peaks and 5 different phosphorylated metabolites were assigned. Representative 2D 1H-31P HSQC TOCSY, 1H-15N HSQC, and 1H-13C HSQC spectra obtained from the E. coli cell lysate are shown in Figure 6. In this manner, the entire detectable 1H-, 13C-, 15N-, and 31P-containing metabolome is completely characterized from a single sample using three different 2D NMR spectra. Although the entire multi-nuclei metabolomics process requires additional sample handling and multiple pH changes, a comparison of the 2D 1H-13C HSQC spectrum from the multi-nuclei metabolomics dataset to spectra acquired following the traditional 13C labeling method resulted in no detectable variation in the number of peaks or in peak intensities (Figure S3). This observation suggests the composition of a metabonomics sample is relatively stable to wide changes in pH, which is consistent with prior reports.36, 37 Furthermore, the acquisition of a 1D 1H spectrum at pH 7 as part of the multi-nuclei metabolomics protocol permits for straight-forward assignment of metabolites using the abundance of database information that is only available at pH 7. A 2D 1H-31P HSQC TOCSY spectrum was also acquired for M. smegmatis and S. pombe (Figure S4). However, efficient lysing of these cells required a harsher FastPrep bead beating method.38 Consequently, fewer metabolite peaks were observed in the 31P NMR spectra, which could not be assigned to any common metabolite. Clearly, the application of 31P NMR to accurately characterize phosphorus-containing metabolites is restricted to mild-types of cell lysing and extraction techniques. Overall, the multi-nuclei metabolomics protocol is a versatile approach for interrogating metabolomes from a variety of biological sources by using any combination of traditional isotope-labeling schemes and naturally abundant nuclei. In this regard, our multi-nuclei metabolomics protocol can obtain a comprehensive characterization of the entire metabolome.

Figure 6.

Figure 6.

(A) 2D 1H-31P HSQC-TOCSY, (B) 2D 1H-15N HSQC and (C) 2D 1H-13C HSQC spectra collected from an E. coli grown in M9 minimal media supplemented with 15NH3Cl and 13C6 glucose. Cells were harvested during the log phase. The metabolite assignments correspond to 1: glucose-1,6-biphoshphate, 2: glucose-6-phosphate, 3: ribose-5-phosphate, 4: AMP, and 5: glycerol phosphate in (A); 1: arginine, 2: glutamine, 3: asparagine, 4: 5-azacytidine, 5: glutamate in (B); 1: TMSP, 2: valine, 3: alanine, 4: N-acetyl alanine, 5: leucine, 6: beta-leucine, 7: lactate 8: 2-hydroxy-3-methyl butyrate, 9: acetyl carnithine 10: N-acetyl aspartate, 11: N-acetyl glucosamine, 12: ornithine, 13: aminobutyrate, 14: acetate , 15: arginine, 16: N-acetyl ornithine, 17: cystathionine, 18: aminohexanoic acid, 19: 2-hydroxy butyrate 20: malate, 21: pyruvate, 22: lysine, 23: glutamate, 24: glutamine, 25: N-acetyl glutamate, 26: succinate, 27: citrulline, 28: coenzyme A, 29: glucose, 30: fumarate, 31: proline, 32: isoleucine, 33: fructose, 34: glycerol, 35: phosphoenolpyruvate, 36: UDP-glucose, 37: AMP, 38: NAD, and 39: Glucose-6-phosphate in (C).

Conclusions

31P NMR offers significant benefits to the metabolomics field by expanding the coverage of the metabolome, and by enabling the detection of metabolites integral to critical cellular processes, such as energy metabolism and cell signaling. Metabolite assignments may be further validated or confirmed by combining the analysis from multiple NMR spectra. For example, a phosphorus-containing metabolite may be inferred from a 2D 1H-13C HSQC spectrum, but may be directly detected and validated from the 2D 1H-31P HSQC-TOCSY spectrum. Similarly, 13C/15N-SIRM experiments only detect and quantify the amount of the metabolite that is directly derived from the 13C or 15N source. Conversely, the 2D 1H-31P HSQC-TOCSY spectrum will yield the total metabolite concentration. Thus, differences in relative metabolite concentrations from the 2D 1H-13C/15N HSQC and 1H-31P HSQC-TOCSY spectra may provide insights regarding variable nitrogen, carbon and phosphorus flux through different metabolic processes. To capitalize on these advantages, we have described a standard multi-nuclei metabolomics workflow that incorporates 31P NMR into a metabolomics strategy. Our multi-nuclei metabolomics protocol enables the characterization of the entire detectable 1H-, 13C-, 15N-, and 31P-containing metabolome using a single sample and a series of 2D NMR spectra. Again, the availability of different types of 2D NMR spectra will also improve the reliability and accuracy of metabolite assignments. A standard protocol for collecting 2D 1H-31P HSQC-TOCSY spectra as part of a multi-nuclei metabolomics workflow was presented. The coupling constants and TOCSY mixing times for the 2D 1H-31P HSQC-TOCSY pulse sequence were optimized to maximize the detection and annotation of phosphorylated-metabolites. Similarly, sample conditions and metabolome extraction protocols were investigated to enable the sequential detection of 1H-, 13C-, 15N-, and 31P-NMR spectra while minimizing sample handling and preserving phosphorylated metabolites. Accordingly, the 31P-NMR spectra needs to be acquired first. The sample needs to be at a pH of 4 and a temperature of 277K, and a standard phosphate buffer is only added after the 31P-NMR spectra are collected. To facilitate the ready assignment of phosphorus-containing metabolites, a reference library of 1D 31P and 2D 1H-31P HSQC-TOCSY spectra with associated chemical shift assignments was assembled for 38 common phosphorylated-metabolites.

31P NMR avoids the expensive isotope labeling costs encountered with 13C- and 15N-SIRM, and requires minimal instrument time due to its higher intrinsic sensitivity. This is particularly valuable for studies involving animal models or human clinical samples where isotope labeling may be prohibitive. Of course, natural abundant 13C-NMR has been routinely and successfully employed to characterize various clinical metabolomics samples (e.g., urine, serum) or cell extracts.24, 25 Despite the advantages of 31P NMR, there are also notable challenges. Minimal 31P chemical shift dispersion requires 2D NMR experiments for reliable metabolite identification. 31P NMR is also hindered by the low stability of phosphorylated metabolites, which are readily hydrolyzed and may give a false view of the true-biological distribution. Thus, great care is required to preserve phosphorylated-metabolites that includes a low temperature, a methanol:chloroform extraction solvent, and mild cell lysing techniques. Despite these challenges, 31P NMR should be a routine component of a metabolomics study since it can provide valuable information and novel insights that are not achievable by other techniques.

Associated Content

The Supporting Information is available free of charge on the ACS Publications website at DOI:

Materials and methods related to NMR sample preparation; and NMR data acquisition for optimal sample conditions, standard phosphorylated metabolites, and s and metabolite assignments. Figures showing the impact of sample preparation protocols and metabolomics test cases for S. pombe and M. smegmatis. Tables with the list of chemical shifts for phosphorylated metabolites at pH 4, their native pH, and the composition of mixtures used in the study.

Supplementary Material

Supplementary Material

Acknowledgments

This material is based upon work supported by the National Science Foundation under Grant Number (1660921). This work was supported in part by funding from the Redox Biology Center (P30 GM103335, NIGMS), and the Nebraska Center for Integrated Biomolecular Communication (P20 GM113126, NIGMS). The research was performed in facilities renovated with support from the National Institutes of Health (RR015468–01). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.

Footnotes

The authors declare no competing financial interest.

References

  • 1.Gebregiworgis T; Powers R, Application of NMR metabolomics to search for human disease biomarkers. Comb. Chem. High Throughput Screen 2012, 15 (8), 595–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Marshall DD; Powers R, Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics. Prog. Nucl. Magn. Reson. Spectrosc 2017, 100, 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bhinderwala F; Powers R, NMR Metabolomics Protocols for Drug Discovery. In NMR-Based Metabolomics: Methods and Protocols, Gowda GAN; Raftery D, Eds. Springer New York: New York, NY, 2019; pp 265–311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jung Y; Lee J; Kwon J; Lee K-S; Ryu DH; Hwang G-S, Discrimination of the Geographical Origin of Beef by 1H NMR-Based Metabolomics. J. Agric. Food. Chem 2010, 58 (19), 10458–10466. [DOI] [PubMed] [Google Scholar]
  • 5.Amargianitaki M; Spyros A, NMR-based metabolomics in wine quality control and authentication. Chem. Biol. Technol 2017, 4 (1), 9. [Google Scholar]
  • 6.Markley JL; Brüschweiler R; Edison AS; Eghbalnia HR; Powers R; Raftery D; Wishart DS, The future of NMR-based metabolomics. Curr. Opin. Biotechnol 2017, 43, 34–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wishart DS; Jewison T; Guo AC; Wilson M; Knox C; Liu Y; Djoumbou Y; Mandal R; Aziat F; Dong E; Bouatra S; Sinelnikov I; Arndt D; Xia J; Liu P; Yallou F; Bjorndahl T; Perez-Pineiro R; Eisner R; Allen F; Neveu V; Greiner R; Scalbert A, HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res 2013, 41 (Database issue), D801–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bingol K; Zhang F; Bruschweiler-Li L; Brüschweiler R, TOCCATA: A Customized Carbon Total Correlation Spectroscopy NMR Metabolomics Database. Anal. Chem 2012, 84 (21), 9395–9401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Akiyama K; Chikayama E; Yuasa H; Shimada Y; Tohge T; Shinozaki K; Hirai MY; Sakurai T; Kikuchi J; Saito K, PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol 2008, 8 (3–4), 339–45. [PubMed] [Google Scholar]
  • 10.Markley JL; Ulrich EL; Berman HM; Henrick K; Nakamura H; Akutsu H, BioMagResBank (BMRB) as a partner in the Worldwide Protein Data Bank (wwPDB): New policies affecting biomolecular NMR depositions. J. Biomol. NMR 2008, 40, 153–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bingol K; Li D-W; Bruschweiler-Li L; Cabrera OA; Megraw T; Zhang F; Brüschweiler R, Unified and Isomer-Specific NMR Metabolomics Database for the Accurate Analysis of 13C–1H HSQC Spectra. ACS Chem. Biol 2015, 10 (2), 452–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhang F; Brüschweiler R, Robust Deconvolution of Complex Mixtures by Covariance TOCSY Spectroscopy. Angew. Chem., Int. Ed 2007, 46 (15), 2639–2642. [DOI] [PubMed] [Google Scholar]
  • 13.Clendinen CS; Lee-McMullen B; Williams CM; Stupp GS; Vandenborne K; Hahn DA; Walter GA; Edison AS, 13C NMR Metabolomics: Applications at Natural Abundance. Anal. Chem 2014, 86 (18), 9242–9250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Clendinen CS; Pasquel C; Ajredini R; Edison AS, 13C NMR Metabolomics: INADEQUATE Network Analysis. Anal. Chem 2015, 87 (11), 5698–5706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bhinderwala F; Lonergan S; Woods J; Zhou C; Fey PD; Powers R, Expanding the Coverage of the Metabolome with Nitrogen-Based NMR. Anal. Chem 2018, 90 (7), 4521–4528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hattori A; Tsunoda M; Konuma T; Kobayashi M; Nagy T; Glushka J; Tayyari F; McSkimming D; Kannan N; Tojo A; Edison AS; Ito T, Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature 2017, 545, 500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gorenstein DG, Phosphorous-31 NMR: Principles and applications Academic Press: 2012. [Google Scholar]
  • 18.Gradwell MJ; Fan TWM; Lane AN, Analysis of Phosphorylated Metabolites in Crayfish Extracts by Two-Dimensional1H-31P NMR Heteronuclear Total Correlation Spectroscopy (heteroTOCSY). Anal. Biochem 1998, 263 (2), 139–149. [DOI] [PubMed] [Google Scholar]
  • 19.Tolman CJ; Kanodia S; Roberts MF; Daniels L, 31P-NMR spectra of methanogens: 2,3-cyclopyrophosphoglycerate is detectable only in methanobacteria strains. Biochim. Biophys. Acta, Mol. Cell Res 1986, 886 (3), 345–352. [DOI] [PubMed] [Google Scholar]
  • 20.Kühl O, The Range of Chemical Shifts, Coupling Constants, and What Influences Each. In Phosphorus-31 NMR Spectroscopy: A Concise Introduction for the Synthetic Organic and Organometallic Chemist, Kühl O, Ed. Springer Berlin Heidelberg: Berlin, Heidelberg, 2008; pp 7–23. [Google Scholar]
  • 21.Abi-Ghanem J; Heddi B; Foloppe N; Hartmann B, DNA structures from phosphate chemical shifts. Nucleic Acids Res 2009, 38 (3), e18–e18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kellogg GW; Schweitzer BI, Two- and three-dimensional 31P-driven NMR procedures for complete assignment of backbone resonances in oligodeoxyribonucleotides. J. Biomol. NMR 1993, 3 (5), 577–95. [DOI] [PubMed] [Google Scholar]
  • 23.Marino JP; Schwalbe H; Anklin C; Bermel W; Crothers DM; Griesinger C, Three-Dimensional Triple-Resonance 1H, 13C, 31P Experiment: Sequential Through-Bond Correlation of Ribose Protons and Intervening Phosphorus along the RNA Oligonucleotide Backbone. J. Amer. Chem. Soc 1994, 116 (14), 6472–6473. [Google Scholar]
  • 24.Clendinen CS; Lee-McMullen B; Williams CM; Stupp GS; Vandenborne K; Hahn DA; Walter GA; Edison AS, 13C NMR Metabolomics: Applications at Natural Abundance. Anal. Chem 2014, 86 (18), 9242–9250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Edison AS; Le Guennec A; Delaglio F; Kupce E, Practical guidelines for 13C-based NMR metabolomics. Methods Mol. Biol 2019, 2037 (NMR-Based Metabolomics), 69–95. [DOI] [PubMed] [Google Scholar]
  • 26.Kluger R; Wasserstein P; Nakaoka K, Factors controlling association of magnesium ion and acyl phosphates. J. Amer. Chem. Soc 1975, 97 (15), 4298–4303. [Google Scholar]
  • 27.Williams GD; Mosher TJ; Smith MB, Simultaneous Determination of Intracellular Magnesium and pH from the Three 31P NMR Chemical Shifts of ATP. Anal. Biochem 1993, 214 (2), 458–467. [DOI] [PubMed] [Google Scholar]
  • 28.Stein A; Crothers DM, Conformational changes of transfer RNA. The role of magnesium(II). Biochemistry 1976, 15 (1), 160–168. [DOI] [PubMed] [Google Scholar]
  • 29.Gorenstein DG; Kar D, 31P chemical shifts in phosphate diester monoanions. Bond angle and torsional angle effects. Biochem. Biophys. Res. Commun 1975, 65 (3), 1073–1080. [DOI] [PubMed] [Google Scholar]
  • 30.Bhinderwala F; Lonergan S; Woods J; Zhou C; Fey PD; Powers R, Expanding the Coverage of the Metabolome with Nitrogen-Based NMR. Anal. Chem 2018, 90 (7), 4521–4528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tewari YB; Steckler DK; Goldberg RN; Gitomer WL, Thermodynamics of hydrolysis of sugar phosphates. J. Biol. Chem 1988, 263 (8), 3670–5. [PubMed] [Google Scholar]
  • 32.Taqui Khan MM; Srinivas Mohan M, Kinetics of adenosine-5′-triphosphate hydrolysis. J. Inorg. Nucl. Chem 1974, 36 (3), 707–709. [Google Scholar]
  • 33.Worley B; Powers R, Deterministic multidimensional nonuniform gap sampling. J. Magn. Reson 2015, 261 (December 2015), 19–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Webb MR; Standring DN; Knowles JR, Phosphorus-31 nuclear magnetic resonance of dihydroxyacetone phosphate in the presence of triosephosphate isomerase. The question of nonproductive binding of the substrate hydrate. Biochemistry 1977, 16 (12), 2738–41. [DOI] [PubMed] [Google Scholar]
  • 35.Cohn M, Mechanisms of cleavage of glucose-1-phosphate. J. Biol. Chem 1949, 180 (2), 771–781. [PubMed] [Google Scholar]
  • 36.Tredwell GD; Bundy JG; De Iorio M; Ebbels TMD, Modelling the acid/base 1H NMR chemical shift limits of metabolites in human urine. Metabolomics 2016, 12 (10), 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Beneduci A; Chidichimo G; Dardo G; Pontoni G, Highly routinely reproducible alignment of 1H NMR spectral peaks of metabolites in huge sets of urines. Anal. Chim. Acta 2011, 685 (2), 186–195. [DOI] [PubMed] [Google Scholar]
  • 38.Halouska S; Fenton RJ; Barletta RG; Powers R, Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem. Biol 2012, 7 (1), 166–71. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material

RESOURCES